Therefore, in this study, we examined the antitumor effects of the CDK4/6 inhibitor abemaciclib and ABT‐263 using MDA‐MB‐231 and MCF‐7 human breast cancer cell lines and investigated the underlying mechanisms. The gene discussed is CDK4; the disease is breast cancer.